SMS Pharmaceuticals Ltd
SMS Pharmaceuticals is a global player in API manufacturing industry. The company's products include Anti-Ulcer, Anti-fungal, Anti-migraine, Anti- Hypertensive,etc.
- Market Cap ₹ 1,142 Cr.
- Current Price ₹ 135
- High / Low ₹ 145 / 23.6
- Stock P/E 25.4
- Book Value ₹ 45.8
- Dividend Yield 0.19 %
- ROCE 12.5 %
- ROE 9.25 %
- Face Value ₹ 1.00
Pros
- No pros found. Suggest something.
Cons
- The company has delivered a poor sales growth of -6.82% over past five years.
- Company has a low return on equity of 11.99% for last 3 years.
- Dividend payout has been low at 5.61% of profits over last 3 years
- Debtor days have increased from 27.56 to 43.21 days.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | 125 | 135 | 101 | 104 | 117 | 118 | 80 | 96 | 113 | 130 | 149 | |
74 | 101 | 110 | 76 | 88 | 94 | 96 | 60 | 82 | 91 | 106 | 114 | |
Operating Profit | 27 | 24 | 25 | 26 | 16 | 23 | 22 | 20 | 14 | 21 | 24 | 34 |
OPM % | 26% | 19% | 19% | 25% | 15% | 20% | 19% | 25% | 15% | 19% | 18% | 23% |
Other Income | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 |
Interest | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 |
Profit before tax | 19 | 16 | 19 | 19 | 8 | 15 | 14 | 12 | 9 | 14 | 16 | 27 |
Tax % | 50% | 38% | 34% | 35% | 22% | 38% | 34% | 40% | 28% | 33% | 31% | 31% |
Net Profit | 10 | 10 | 13 | 12 | 6 | 9 | 10 | 8 | 6 | 9 | 11 | 18 |
EPS in Rs | 1.15 | 1.19 | 1.48 | 1.44 | 0.77 | 1.12 | 1.13 | 0.89 | 0.74 | 1.09 | 1.33 | 2.16 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
241 | 215 | 226 | 217 | 248 | 518 | 587 | 611 | 438 | 463 | 465 | 412 | 488 | |
221 | 197 | 187 | 179 | 285 | 461 | 500 | 522 | 363 | 369 | 375 | 332 | 394 | |
Operating Profit | 20 | 17 | 39 | 38 | -37 | 57 | 86 | 89 | 75 | 93 | 90 | 80 | 94 |
OPM % | 8% | 8% | 17% | 17% | -15% | 11% | 15% | 15% | 17% | 20% | 19% | 19% | 19% |
Other Income | 4 | 7 | 2 | 1 | 105 | 2 | 16 | 4 | 1 | 2 | 3 | 5 | 6 |
Interest | 10 | 14 | 18 | 24 | 24 | 14 | 18 | 17 | 16 | 15 | 12 | 12 | 11 |
Depreciation | 6 | 8 | 13 | 13 | 14 | 13 | 17 | 19 | 19 | 20 | 19 | 22 | 23 |
Profit before tax | 8 | 3 | 10 | 1 | 30 | 32 | 67 | 56 | 42 | 60 | 62 | 51 | 65 |
Tax % | 21% | 17% | 20% | 20% | 15% | 36% | 48% | 26% | 14% | 33% | 34% | 36% | |
Net Profit | 6 | 2 | 8 | 1 | 25 | 20 | 35 | 42 | 36 | 40 | 41 | 33 | 45 |
EPS in Rs | 0.63 | 0.24 | 0.84 | 0.11 | 2.53 | 2.40 | 4.15 | 4.92 | 4.20 | 4.78 | 4.89 | 3.86 | 5.32 |
Dividend Payout % | 32% | 42% | 18% | 0% | 8% | 8% | 5% | 4% | 5% | 5% | 5% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | -7% |
3 Years: | -2% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | -1% |
3 Years: | -3% |
TTM: | 36% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 12% |
3 Years: | 16% |
1 Year: | 275% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 13% |
3 Years: | 12% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | 10 | 10 | 10 | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | |
Reserves | 202 | 203 | 210 | 211 | 234 | 213 | 246 | 286 | 254 | 293 | 331 | 359 | 379 |
Borrowings | 137 | 163 | 187 | 207 | 149 | 167 | 167 | 204 | 149 | 146 | 144 | 157 | 145 |
49 | 59 | 64 | 64 | 79 | 120 | 119 | 158 | 89 | 72 | 93 | 103 | 179 | |
Total Liabilities | 398 | 435 | 471 | 492 | 471 | 509 | 540 | 656 | 501 | 519 | 577 | 627 | 712 |
87 | 217 | 206 | 225 | 147 | 247 | 277 | 370 | 290 | 279 | 281 | 280 | 271 | |
CWIP | 120 | 37 | 59 | 49 | 96 | 39 | 29 | 13 | 8 | 8 | 18 | 42 | 99 |
Investments | 1 | 1 | 1 | 1 | 26 | 6 | 13 | 21 | 37 | 45 | 45 | 45 | 45 |
190 | 181 | 206 | 217 | 203 | 217 | 221 | 252 | 166 | 187 | 232 | 259 | 297 | |
Total Assets | 398 | 435 | 471 | 492 | 471 | 509 | 540 | 656 | 501 | 519 | 577 | 627 | 712 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | 25 | 15 | 20 | -33 | 65 | 59 | 61 | 73 | 32 | 50 | 40 | |
-66 | -58 | -26 | 25 | 99 | -37 | -55 | -79 | -39 | -17 | -35 | -43 | |
42 | 18 | 12 | 8 | -59 | -30 | -10 | 27 | -33 | -15 | -13 | -2 | |
Net Cash Flow | -3 | -15 | 1 | 52 | 7 | -2 | -6 | 9 | 1 | 0 | 2 | -5 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 5% | 5% | 7% | 6% | -12% | 12% | 21% | 16% | 13% | 18% | 16% | 13% |
Debtor Days | 74 | 82 | 67 | 65 | 52 | 39 | 37 | 36 | 18 | 19 | 20 | 43 |
Inventory Turnover | 2.75 | 2.21 | 1.56 | 1.08 | 1.85 | 4.03 | 4.71 | 4.26 | 3.06 | 3.12 | 2.58 | 2.00 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Feb
- Outcome Of Board Meeting Held On 10Th February, 2021 10 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb
- Board Meeting Intimation for Notice Of Board Meeting To Be Held On 10.02.2021 3 Feb
- Reporting To SEBI Regarding Acquisition Of Shares By Inter Se Transfer Ref: Regulation 10(7) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 12 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse
- Financial Year 2009 from nse